Your browser doesn't support javascript.
loading
The Long Noncoding RNA NEAT1 Promotes Sarcoma Metastasis by Regulating RNA Splicing Pathways.
Huang, Jianguo; Sachdeva, Mohit; Xu, Eric; Robinson, Timothy J; Luo, Lixia; Ma, Yan; Williams, Nerissa T; Lopez, Omar; Cervia, Lisa D; Yuan, Fan; Qin, Xiaodi; Zhang, Dadong; Owzar, Kouros; Gokgoz, Nalan; Seto, Andrew; Okada, Tomoyo; Singer, Samuel; Andrulis, Irene L; Wunder, Jay S; Lazar, Alexander J; Rubin, Brian P; Pipho, Krista; Mello, Stephano S; Giudice, Jimena; Kirsch, David G.
Afiliación
  • Huang J; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
  • Sachdeva M; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
  • Xu E; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
  • Robinson TJ; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
  • Luo L; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
  • Ma Y; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
  • Williams NT; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
  • Lopez O; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina.
  • Cervia LD; Department of Biomedical Engineering, Duke University, Durham, North Carolina.
  • Yuan F; Department of Biomedical Engineering, Duke University, Durham, North Carolina.
  • Qin X; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
  • Zhang D; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
  • Owzar K; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
  • Gokgoz N; Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina.
  • Seto A; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Okada T; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Singer S; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Andrulis IL; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Wunder JS; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Lazar AJ; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Rubin BP; University of Toronto Musculoskeletal Oncology Unit, and Department of Surgery, University of Toronto, Toronto, Canada.
  • Pipho K; Departments of Pathology, Genomic Medicine, and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mello SS; Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
  • Giudice J; University of Rochester Medical Center, Rochester, New York.
  • Kirsch DG; University of Rochester Medical Center, Rochester, New York.
Mol Cancer Res ; 18(10): 1534-1544, 2020 10.
Article en En | MEDLINE | ID: mdl-32561656
ABSTRACT
Soft-tissue sarcomas (STS) are rare malignancies showing lineage differentiation toward diverse mesenchymal tissues. Half of all high-grade STSs develop lung metastasis with a median survival of 15 months. Here, we used a genetically engineered mouse model that mimics undifferentiated pleomorphic sarcoma (UPS) to study the molecular mechanisms driving metastasis. High-grade sarcomas were generated with Cre recombinase technology using mice with conditional mutations in Kras and Trp53 (KP) genes. After amputation of the limb bearing the primary tumor, mice were followed for the development of lung metastasis. Using RNA-sequencing of matched primary KP tumors and lung metastases, we found that the long noncoding RNA (lncRNA) Nuclear Enriched Abundant Transcript 1 (Neat1) is significantly upregulated in lung metastases. Furthermore, NEAT1 RNA ISH of human UPS showed that NEAT1 is upregulated within a subset of lung metastases compared with paired primary UPS. Remarkably, CRISPR/Cas9-mediated knockout of Neat1 suppressed the ability of KP tumor cells to colonize the lungs. To gain insight into the underlying mechanisms by which the lncRNA Neat1 promotes sarcoma metastasis, we pulled down Neat1 RNA and used mass spectrometry to identify interacting proteins. Interestingly, most Neat1 interacting proteins are involved in RNA splicing regulation. In particular, KH-Type Splicing Regulatory Protein (KHSRP) interacts with Neat1 and is associated with poor prognosis of human STS. Moreover, depletion of KHSRP suppressed the ability of KP tumor cells to colonize the lungs. Collectively, these results suggest that Neat1 and its interacting proteins, which regulate RNA splicing, are involved in mediating sarcoma metastasis. IMPLICATIONS Understanding that lncRNA NEAT1 promotes sarcoma metastasis, at least in part, through interacting with the RNA splicing regulator KHSRP may translate into new therapeutic approaches for sarcoma.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Empalme del ARN / ARN Largo no Codificante Límite: Humans Idioma: En Revista: Mol Cancer Res Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Empalme del ARN / ARN Largo no Codificante Límite: Humans Idioma: En Revista: Mol Cancer Res Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2020 Tipo del documento: Article